Biocom California
Adam Watson, PhD, is a prominent figure in the healthcare and diagnostics field, serving as Co-Founder and CEO of MeCo Diagnostics. Additionally, Adam holds membership positions with the American Cancer Society National Breast Cancer Roundtable and Biocom California's Medical Device and Diagnostics Committee. Adam contributes as an Entrepreneur in Residence at EvoNexus and also acts as a Grants Reviewer for Genome Canada. Adam's academic background includes a Doctor of Philosophy in Cancer Biology from the University of Arizona and a Bachelor of Science in Microbiology from the University of Victoria.
This person is not in the org chart
This person is not in any teams
Biocom California
Biocom is a business advocate for life sciences companies in California. It represents more than 750 biotechnology, pharmaceutical, digital health, and medical device or diagnostic companies. The company focuses on accelerating the innovation ecosystem and introducing inventive purchasing programs that advance day-to-day business activities.Biocom provides a public voice to the companies and organizations that support local economies and produce novel solutions to improve the human condition. The company’s membership benefits apply to biotechnology, pharmaceutical, medical device, genomics, and diagnostics companies of all sizes as well as to research universities and institutes, CROs, investors, and service providers.Biocom’s main offices are located in San Diego and Los Angeles, with satellite offices in Washington, D.C. and Tokyo.